Angle Orthod. 2019 Jul;89(4):535-543. doi: 10.2319/032918-239.1. Epub 2019 Feb 5.
To assess the prevalence and magnitude of labial gingival recession (LGR) before and after as well as the incidence during Class II:1 Herbst-Multibracket appliance (Herbst-MBA) treatment (Tx) plus retention in a retrospective cohort study.
Records of Class II:1 patients who completed Herbst-MBA Tx (mean pre-Tx age 14.4 years) at Department of Orthodontics, University of Giessen, Giessen, Germany were analyzed. Tx consisted of a Herbst phase (mean 8.1 months) and a subsequent MBA phase (mean 16.1 months). Study casts from before and after Herbst-MBA Tx plus ≥24 months of retention were evaluated.
A total of 460 pre-Tx and 222 postretention study casts were available (total observation period: 59.2 ± 14.8 months). The overall prevalence for teeth with LGR ≥0.5 mm was 1.1% pre-Tx and 5.3% postretention. The highest prevalence of up to 5.3% (pre-Tx) and 16.4% (postretention) were seen for the lower incisors. Overall, the median magnitude of LGR was 0.0 mm pre-Tx/postretention (mean: 0.05 mm/0.08 mm). Incidence values of 4.0% (all teeth) and 10.0% to 11.4% (lower central incisors) were calculated for LGR ≥0.5 mm.
The prevalence of LGR ≥0.5 mm increased from, on average, 1.1% to 5.3% during ≈6 years of Herbst-MBA Tx plus retention. The highest incidence was seen in lower incisors (10.0%-11.4%). However, because of the overall mean magnitude of 0.08 mm postretention, the clinical relevance can be considered as insignificant.
在回顾性队列研究中,评估 II 类 1 分类上颌前牵引(Herbst-MBA)治疗(Tx)前后以及治疗期间唇侧牙龈退缩(LGR)的发生率。
分析了德国吉森大学正畸科完成 II 类 1 分类 Herbst-MBA Tx(平均治疗前年龄 14.4 岁)的患者记录。Tx 由 Herbst 阶段(平均 8.1 个月)和随后的 MBA 阶段(平均 16.1 个月)组成。评估了 Herbst-MBA Tx 前后以及至少 24 个月保持器治疗的研究模型。
共有 460 个治疗前和 222 个保持器治疗后研究模型(总观察期:59.2±14.8 个月)。LGR≥0.5mm 的牙齿总体患病率为治疗前 1.1%,保持器治疗后 5.3%。下切牙的患病率最高,高达 5.3%(治疗前)和 16.4%(保持器治疗后)。总体而言,LGR 的中位数为 0.0mm 治疗前/保持器治疗后(平均:0.05mm/0.08mm)。计算出 LGR≥0.5mm 的发生率为 4.0%(所有牙齿)和 10.0%至 11.4%(下中切牙)。
在大约 6 年的 Herbst-MBA Tx 加保持器治疗期间,LGR≥0.5mm 的患病率从平均 1.1%增加到 5.3%。下切牙的发生率最高(10.0%-11.4%)。然而,由于保持器治疗后平均 0.08mm 的总体幅度,临床相关性可被认为不显著。